Cardiovascular mortality and morbidity in type-2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 31, Issue SUPPL., 1996, Pages

  Schernthaner, G ^a  

^a Rudolfstiftung   (Austria)

Author keywords

Cardiovascular morbidity; Coagulation; Endothelial dysfunction; Mortality; Silent ischemia

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

EID: 0029739373     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01224-7     Document Type: Conference Paper

References (48)

1. Pyöräla, K., Laakso, M. and Uusitopa, M. (1987) Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab. Rev. 3, 463-524.
2. Uusitupa, M.I.J., Niskanen, L.K., Siitonen, O., Voutilainen, E. and Pyörälä, K. (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type-2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36, 1175-1184.
3. Uusitupa, M.I.J., Niskanen, L.K., Siitonen, O., Voutilalnen, E. and Pyörälä, K. (1990) 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 82, 27-36.
4. Laakso, M., Lehto, S., Penttilä, I. and Pyörälä, K. (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88, 1421-1430.
5. Kuusisto, J., Mykkänen, L., Pyörälä, K. and Laakso, M. (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43, 960-967.
6. Balkau, B., Eschwege, E., Papoz, L., Richard, J.L., Claude, J.R., Warnet, J.M and Ducimetiére, P. (1993) Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. Br. Med. J. 307, 295-299.
7. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41, 202-208.
8. Kannel, W.B. and McGee, D.L. (1979) Diabetes and cardiovascular disease. The Framingham Study. J. Am. Med. Assoc. 241, 2-2038.
9. Ganda, O.M.P. and Arkin, C.H.F. (1992) Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care 15, 1245-1250.
10. Kannel, W.B. and McGee, D.L. (1979) Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 1, 8-13.
11. Pan, W.B., Cedres, L.B., Liu, K., Dyer, A., Schoenberger, J.A., Shekeile, R.B et al. (1986) Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am. J. Epidemiol. 123, 504-516.
12. Stamler, J., Vaccaro, O., Neaton, J.D., Wentworth, D. for The Multiple Risk Factor Intervention Trial Group (1993) Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16, 434-444.
13. Janka, H.U., Ziegler, A.G., Standl, E. and Mehnert, H. (1987) Daily insulin dose as a predictor of macrovascular disease in insulin-treated non-insulin-dependent diabetics. Diabetes Metab. 13, 359-364.
14. Fontbonne, A., Charles, M.A., Thibult, N., Richard, J.L., Claude, J.R., Warnet, J.M. et al. (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population. The Paris Prospective Study. 15 years follow-up. Diabetologia 34, 356-361.
15. Eschwege, E., Balkau, B. and Fontbonne, A. (1994) The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. J. Intern. Med. 236(Suppl. 736), 5-11.
16. Jarrett, R.J. and Shipley, M.J. (1988) Type-2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease - putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia 31, 737-740.
17. Uusitupa, M.I.J., Niskanen, L.K., Slitonen, O., Voutilainen, E. and Pyörälä, K. (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type-2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36, 1175-1184.
18. Barren-Connor, E. and Wingard, D.L. (1983) Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am. J. Epidemiol. 118, 489-496.
19. Jarrett, R.J. (1984) Type-2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia 26, 99-102.
20. Rosengren, A., Welin, L., Tsipogianni, A. and Wilhemsen, L. (1989) Impact of cardiovascular risk factors on coronary heart disease and mortality among middle-aged diabetic men: a general population study. Br. Med. J. 299, 1127-1131.
21. Uusitupa, M., Siitonen, O., Aro, A. and Pyörälä, K. (1985) Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type-2 (non-insulin-dependent) diabetic subjects. Diabetologia 28, 22-27.
22. Meade, T.W., Mellows, S., Brozovic, M., Miller, G.J., Chakrabarti, R.R., North, W.R.S., Haines, A.P., Stirling, Y., Imeson, J.D. and Thompson, S.G. (1986) Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 2, 533-537.
23. Thompson, S.G., Kienast, J., Pyke, S., Haverkate, F. and Van der Looo, J. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N. Engl. J. Med. 332, 635-641.
24. Balkau, B., Eschwege, E., Fontbonne, A., Claude, J.R. and Warnet, J.M. (1992) Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects. Diabetologia 35, 39-44.
25. Muggeo, M., Verlato, G., Bonora, E., Bressan, F., Girotto, S., Corbeilini, M., Gemma, M.L., Moghetti, P., Zenere, M., Cacciatori, V., Zoppini, G. and De Marco, R. (1995) The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year allcause mortality. Diabetologia 38, 318-325.
26. Muggeo, M., Verlato, G., Bonora, E., Ciani, F., Moghetti, P., Eastam, R., Crepaldi, G. and De Marco, R. (1995) Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: The Verona Diabetes Study. Diabetologia 38, 672-679.
27. Waugh, N.R., Dallas, J.H., Jung, R.T. and Newton, R.W. (1989) Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 32, 103-104.
28. Wong, J.S.K., Pearson, D.W.M., Murchison, L.E., Williams, M.J. and Narayan, V. (1991) Mortality in diabetes mellitus: experience of a geographically defined population. Diabet. Med. 8, 135-139.
29. Orlander, P.H.R., Goff, D.C., Morrissey, M., Ramsey, D.J., Wear, M.L., Labarthe, D.R. and Nichaman, M.Z. (1994) The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. Diabetes 43, 897-902.
30. Herlitz, J., Malmberg, K., Karlson, B.W., Ryden, L. and Hjalmarson, A. (1988) Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med. Scand. 224, 31-38.
31. Zuanetti, G., Latini, R., Maggioni, A.P., Santoro, L. and Franzosi, M.G. (1993) Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. JACC 22, 1788-1794.
32. Yudkin, J.S. and Oswald, G.A. (1988) Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11, 351-358.
33. Gray, R.P., Yudkin, J.S. and Patterson, D.L. (1993) Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor. Br. Heart J. 70, 530-536.
34. Bradley, R.F. and Schonfeld, A. (1962) Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics 17, 322-326.
35. Margolis, J.R., Kannei, W.B., Feinleib, M., Dawber, T.R. and McNamara, P.M. (1973) Clinical features of unrecognized myocardial infarction - silent and symptomatic. Eighteen-year follow-up: the Framingham Study. Am. J. Cardiol. 32, 1-5.
36. Nesto, R.W., Watson, F.S., Kowalchuk, G.J. et al. (1990) Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyramidole thallium 201 scintigraphy. Am. Heart J. 120, 1073-1077.
37. Koistinen, M.J., Huikuri, H.V., Pirttiaho, H., Linnaluoto, M.K. and Takkunen, J.T. (1990) Evaluation of exercise, electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. Br. Heart J. 63, 7-11.
38. Chiarello, M., Indolfi, C., Cotecchia, M.R., Sifoly, C., Romano, M. and Condorelli, M. (1985) Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am. Heart J. 110, 529-534.
39. Naka, M., Hiramatsu, K., Aizawa, T. et al. (1992) Silent myocardial ischaemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am. Heart J. 123, 46-53.
40. Schernthaner, G. (1993) Microalbuminuria in non-insulin-dependent diabetes mellitus. In: C.E. Mogensen (Ed.), Microalbuminuria. A Marker for Organ Damage, Science Press, Oxford, pp. 29-43
41. Knöbl, P., Schernthaner, G., Schnack, Ch., Pietschmann, P., Griessmacher, A., Prager, R. and Müller, M. (1993) Thrombogenic factors are related to urinary albumin excretion rate in type 1 and type 2 diabetic patients. Diabetologia 36, 1045-1050.
42. Griesmacher, A., Kindhauser, M., Andert, S., Schreiner, W., Toma, C., Knöbl, P., Pietschmann, P., Prager, R., Schnack, Ch., Schernthaner, G. and Müller, M.M. (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am. J. Med. 98, 468-475.
43. Jensen, T., Bjerre-Knudsen, J., Feldt-Rasmussen, B. and Deckert, T. (1989) Features of endothelial cell dysfunction in early diabetic nephropathy. Lancet I, 461-463.
44. Stehouwer, C.D.A., Nauta, J.J.P., Zeldenrust, G.C., Hackeng, W.E.L.D., Donker, A.J.M. and den Ottolander, G.J.H. (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340, 319-323.
45. Collier, A., Rumley, A., Rumley, A.G. et al. (1992) Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 41, 909-913.
46. Knöbl, P., Schernthaner, G., Schnack, Ch., Pietschmann, P., Proidl, S., Prager, R. and Vukovich, Th. (1994) Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb. Haemostasis 71, 692-697.
47. Fu, C., Chang, C., Tseng, C., Chen, M., Kao, C., Wu, T., Wu, H., Chuang, I., Chen, C. and Tai, T. (1993) Development of macrovascular disease in NIDDM patients in northern Taiwan. Diabetes Care 16, 137-143.
48. The Diabetes Control and Complications Trial (DCCT) Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.